Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919386 · ClinicalTrials.gov registry record
Ureteral Stent Size Measurement Study
A clinical trial, sponsored by CAMC Health System.
- Completed
- Registry status
- 17
- Enrollment target
NCT00919386: Completed study, sponsored by CAMC Health System.
NCT00919386 is a clinical trial that has completed, run by CAMC Health System. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00919386 has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
To examine a patient's quality of life using three methods for measuring stent size: (a) direct measurement, (b) patient height, and (c) a standardized formula. The intent of the study is to show if there is a difference in a patient's quality of life, postoperative symptoms, pain medication and anticholinergic use by using one of these specific methods for stent size determination. No method is interventional in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-05 |
What the finished NCT00919386 record still lists
NCT00919386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00919386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00919386 about?
NCT00919386 is a clinical study titled "Ureteral Stent Size Measurement Study". To examine a patient's quality of life using three methods for measuring stent size: (a) direct measurement, (b) patient height, and (c) a standardized formula. The intent of the study is to show if there is a difference in a patient's quality of life, postoperative symptoms, pain medication and ant...
What is the current status of trial NCT00919386?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2009-04. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT00919386?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia